Dry eye common in postmenopausal women; mechanism unclear

Article

Meibomian gland dysfunction is a common contributor to dry eye disease, especially in postmenopausal women. Dry eye disease occurs more frequently in women, and increases with advancing age.

Seattle-Meibomian gland dysfunction is a common contributor to dry eye disease, especially in postmenopausal women. Dry eye disease occurs more frequently in women, and increases with advancing age. 

In a study presented at the annual meeting of the American Academy of Optometry in Seattle, Lisa Jones-Jordan, PhD, and colleagues attempted to determine the prevalence of dry eye in postmenopausal women, as well as to evaluate the distribution of aqueous deficient, evaporative, and mixed etiology in this population.

“As we know, dry eye disease appears more in women, and [increases with age],” said Dr. Jones-Jordan, a research associate professor in the College of Optometry at The Ohio State University.  “There is not really enough tear production, and there may be a function of some kind of dysfunction.”

There are new diagnostic techniques and potential treatment options, but there is a lack of information on how we should be treating dry eye.

“The existing estimates for the prevalence of dry eye does not reflect the current understanding,” said Dr. Jones-Jordan.

Researchers looked at two sets of postmenopausal women (n = 440 and n = 499; N = 939) and combined them to evaluate clinical dry eye examination findings including: the Schirmer test, meibomian gland (MG) status (gland blockage 0-3), and symptoms.

Of this group, roughly two-thirds of women (62.5%) met the criteria for one of the categories of dry eye. In addition, 11.1% were classified as normal, and 26.4% did not meet any of the criteria. When the researchers included symptomatology in the classification, fewer women met the criteria for having dry eye (11.6% of the sample). This demonstrates the variability in symptom reporting combined with diagnostic testing.

“We found that meibomian gland dysfunction play a role in developing dry eye dysfunction,” said Dr. Jones-Jordan, and adds that further study is needed to determine whether meibomian changes occur as part of the dry eye disease process or as a normal part of aging.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.